Cargando…
281. Prevalence of Influenza Co-infection in a Real-world Cohort of COVID-19 Patients in the U.S
BACKGROUND: Over 29 million people have been infected with COVID-19 in the U.S. alone. While COVID-19 carries serious morbidity and mortality, potential for co-infection with other respiratory infections remains unclear. We aimed to: (1) estimate co-infection prevalence of COVID-19 and influenza, an...
Autores principales: | Chawla, Devika, Chen, Xin, Kuhlbusch, Klaus, Zalocusky, Kelly, Rizzo, Shemra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644958/ http://dx.doi.org/10.1093/ofid/ofab466.483 |
Ejemplares similares
-
322. Risk Factors for COVID-19 Disease Severity Using Electronic-Health Records in a Real-World Cohort in the United States
por: Rizzo, Shemra, et al.
Publicado: (2021) -
26. Risk of Post–COVID-19 Dyspnea and Interstitial Lung Disease (ILD) in a Real-World Cohort of Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021) -
515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021) -
2647. Influenza Treatment Rates in UK Primary Care Settings: Real-World Data Analysis of the CPRD, 2003–2018
por: Chawla, Devika, et al.
Publicado: (2019) -
1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
por: Neuberger, Eddie, et al.
Publicado: (2020)